Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson's disease

被引:1
|
作者
Neufeld, Paula Maria [1 ]
Nettersheim, Ralf A. [2 ]
Matschke, Veronika [1 ]
Vorgerd, Matthias [3 ]
Stahlke, Sarah [1 ]
Theiss, Carsten [1 ]
机构
[1] Ruhr Univ Bochum, Inst Anat, Med Fac, Dept Cytol, Bochum, Germany
[2] Ruhr Univ Bochum, Univ Hosp Bergmannsheil, Dept Visceral Surg, Bochum, Germany
[3] Ruhr Univ Bochum, Univ Hosp Bergmannsheil, Heimer Inst Muscle Res, Dept Neurol, Bochum, Germany
关键词
diet; gut-brain axis; microbiome; neurodegenerative diseases; nutrition; Parkinson's disease; progesterone; steroid hormones; ENTERIC NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; PROGESTERONE; MICROBIOTA; NEUROSTEROIDS; INFLAMMATION; PATHOLOGY; DIET;
D O I
10.4103/1673-5374.391304
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This comprehensive review explores the intricate relationship between nutrition, the gut microbiome, steroid hormones, and Parkinson's disease within the context of the gut-brain axis. The gut-brain axis plays a pivotal role in neurodegenerative diseases like Parkinson's disease, encompassing diverse components such as the gut microbiota, immune system, metabolism, and neural pathways. The gut microbiome, profoundly influenced by dietary factors, emerges as a key player. Nutrition during the first 1000 days of life shapes the gut microbiota composition, influencing immune responses and impacting both child development and adult health. High-fat, high-sugar diets can disrupt this delicate balance, contributing to inflammation and immune dysfunction. Exploring nutritional strategies, the Mediterranean diet's anti-inflammatory and antioxidant properties show promise in reducing Parkinson's disease risk. Microbiome-targeted dietary approaches and the ketogenic diet hold the potential in improving brain disorders. Beyond nutrition, emerging research uncovers potential interactions between steroid hormones, nutrition, and Parkinson's disease. Progesterone, with its anti-inflammatory properties and presence in the nervous system, offers a novel option for Parkinson's disease therapy. Its ability to enhance neuroprotection within the enteric nervous system presents exciting prospects. The review addresses the hypothesis that alpha-synuclein aggregates originate from the gut and may enter the brain via the vagus nerve. Gastrointestinal symptoms preceding motor symptoms support this hypothesis. Dysfunctional gut-brain signaling during gut dysbiosis contributes to inflammation and neurotransmitter imbalances, emphasizing the potential of microbiota-based interventions. In summary, this review uncovers the complex web of interactions between nutrition, the gut microbiome, steroid hormones, and Parkinson's disease within the gut-brain axis framework. Understanding these connections not only offers novel therapeutic insights but also illuminates the origins of neurodegenerative diseases such as Parkinson's disease.
引用
收藏
页码:2219 / 2228
页数:10
相关论文
共 50 条
  • [21] The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate
    Gorecki, Anastazja M.
    Dunlop, Sarah A.
    Rodger, Jennifer
    Anderton, Ryan S.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (07) : 601 - 604
  • [22] The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance
    Menozzi, Elisa
    Macnaughtan, Jane
    Schapira, Anthony H. V.
    ANNALS OF MEDICINE, 2021, 53 (01) : 611 - 625
  • [23] The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
    Perez-Pardo, Paula
    Kliest, Tessa
    Dodiya, Hemraj B.
    Broersen, Laus M.
    Garssen, Johan
    Keshavarzian, Ali
    Kraneveld, Aletta D.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 817 : 86 - 95
  • [24] 2021 Workshop: Neurodegenerative Diseases in the Gut-Brain Axis-Parkinson's Disease
    Mawe, Gary M.
    Browning, Kirsteen N.
    Manfredsson, Fredric P.
    Camilleri, Michael
    Hamilton, Frank A.
    Hollander, Jonathan A.
    Sieber, Beth-Anne
    Greenwel, Patricia
    Shea-Donohue, Terez
    Wiley, John W.
    GASTROENTEROLOGY, 2022, 162 (06) : 1574 - 1582
  • [25] The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
    Madelyn C. Houser
    Malú G. Tansey
    npj Parkinson's Disease, 3
  • [26] Gut-brain axis: Review on the association between Parkinson's disease and plant lectins
    Moin, Kayvon
    Funk, Carly
    Josephs, Meagan
    Coombes, Kyle
    Yeakle, Madeleine
    Gala, Dhir
    Ahmed-Khan, Mohammad
    ARCHIVE OF CLINICAL CASES, 2022, 9 (04): : 177 - 183
  • [27] Autism and nutrition: the role of the gut-brain axis
    van De Sande, Marijke M. H.
    van Buul, Vincent J.
    Brouns, Fred J. P. H.
    NUTRITION RESEARCH REVIEWS, 2014, 27 (02) : 199 - 214
  • [28] The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
    Houser, Madelyn C.
    Tansey, Malu G.
    NPJ PARKINSONS DISEASE, 2017, 3
  • [29] Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease
    Riegelman, Elizabeth
    Xue, Kathy S.
    Wang, Jia-Sheng
    Tang, Lili
    NUTRIENTS, 2024, 16 (13)
  • [30] Evaluation of bidirectional gut-brain axis and anorectal function in Parkinson's disease with constipation
    Yan, Yun
    Tennekoon, Karunaratne
    Eubanks, Audrey
    Herekar, Anam
    Shimoga, Dhanush
    Ayyala, Deepak
    Mcleod, Colin
    Kurek, Julie A.
    Morgan, John C.
    Rao, Satish S. C.
    Sharma, Amol
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36 (03):